Xiaojian Yan
Fujian Normal University(CN)Wenzhou Medical University(CN)First Affiliated Hospital of Wenzhou Medical University(CN)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Cancer-related molecular mechanisms research, Endometriosis Research and Treatment, PARP inhibition in cancer therapy
Most-Cited Works
- → Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer(2018)1,831 cited
- → Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆(2021)198 cited
- → Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer(2019)132 cited
- → Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells(2014)88 cited
- → Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China(2024)81 cited
- → Triterpenoids as reversal agents for anticancer drug resistance treatment